MedTech Dive June 17, 2025
A nonprofit led by the co-founder and former CEO of 23andMe outbid competitors for nearly all of the company’s assets.
Dive Brief:
- Anne Wojcicki, co-founder and former CEO of 23andMe, will buy back “substantially all” of the genetic testing firm’s assets, 23andMe announced Friday. A bankruptcy court must still approve the sale.
- The nonprofit TTAM Research Institute — an acronym for 23andMe — outbid Regeneron with a purchase price of $305 million. Biotechnology firm Regeneron had offered $256 million, and the company was selected as the backup bidder, according to the announcement. The Wall Street Journal first reported TTAM’s winning bid.
- Wojcicki previously tried to take 23andMe private, but two offers were rejected by the company’s board. Wojcicki...
Today's Sponsors
Today's Sponsor